tirzepatide weight loss nejm Tirzepatide: In the SURMOUNT-1 trial, reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056 select trial semaglutide nejm Tirzepatide

A licensed healthcare provider should review your medical history, current medicines and treatment goals before use to reduce risks and guide safe, effective use as prescribed for your condition

Your FTO gene variant (rs9939609) and MC4R polymorphisms (rs17782313) influence how strongly your brain responds to GLP-1 signaling and whether you're naturally predisposed to carbohydrate cravings

Interest in Retatrutide increased significantly following early clinical trial data exploring its effects on body weight and metabolic signalling

Declining estrogen levels with menopause speed up bone loss, according to the American Academy of Orthopaedic Surgeons